Kandel
and colleagues at the Pediatric Tumor Biology Laboratory were the first to describe how experimental pediatric tumor
growth could be
suppressed by blocking a molecule called vascular endothelial
growth factor (VEGF) from performing its natural
job.
Reasons for success in Athens parallel those in Ann Arbor — good
job growth (the employment base expanded 8.8 % in 2016
and 2017)
and generally
suppressed supply (the most recent construction in Athens completed in 2015).